# Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

> **NCT02654483** · PHASE2 · COMPLETED · sponsor: **Jean Yuh Tang** · enrollment: 14 (actual)

## Conditions studied

- Epidermolysis Bullosa
- Pruritus

## Interventions

- **DRUG:** VPD-737
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02654483
- **Lead sponsor:** Jean Yuh Tang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-31
- **Primary completion:** 2018-06-28
- **Final completion:** 2018-07-27
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-03-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02654483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02654483, "Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02654483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*